Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT

Myeloproliferative Neoplasms (MPNs)
Do you want to read an article? Please log in or register.